Breaking News

Valeant To Acquire Obagi

March 26, 2013

Professional skin care brand worth $360 million in deal.

Valeant Pharmaceuticals International Inc. has entered into an agreement to acquire Obagi Medical Products Inc. According to reports, Valeant will acquire all the outstanding common stock of Obagi for $19.75 a share in cash, or $360 million.


The professional skin-care company founded by Beverly Hills-based dermatologist Zein Obagi. The Obagi brand, founded in 1988 with the creation of the Obagi Nu-Derm System, is only available through medical professionals. Dr. Obagi sold his controlling interest to outside investors in 1997


At press time, the Obagi board approved the offer, and both companies expect the transaction to be completed in the second quarter of 2013.


blog comments powered by Disqus
  • Start Stuffing The Ballot Box (Again)!

    Start Stuffing The Ballot Box (Again)!

    June 28, 2016
    Vote on the finalists in Happi's reader's choice Anti-Aging Product of the Year contest!

  • What

    What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 27, 2016
    Euromonitor weighs in on how Brexit could impact consumer product companies.

  • The Future of Innovation

    The Future of Innovation

    Nancy Jeffries, Contributing Editor||June 27, 2016
    Fashion Institute of Technology graduate students tackle a far-reaching topic for their Capstone project.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.